Biotech | December 13, 2021
Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
It is a novel oral NLRP3 inflammasome inhibitor
It is a novel oral NLRP3 inflammasome inhibitor
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
Whipple procedure is a very complex operation, mainly performed to remove pancreatic cancer
Approximately five kg tumor was removed in the eight-hour long complicated surgery
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
It is estimated that one-third of our country’s population has some form of these disorders
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma
Acute therapies continue to report strong growth compared to chronic ones.
_256_384.jpg)
It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis
Subscribe To Our Newsletter & Stay Updated
